Drug Profile
Coronavirus vaccine - GSK/Institut Pasteur
Alternative Names: SARS vaccine - GSK/Institut PasteurLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline; Institut Pasteur
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Severe acute respiratory syndrome
Most Recent Events
- 27 Aug 2007 No development reported - Preclinical for Severe acute respiratory syndrome (prevention) in Belgium (unspecified route)
- 27 Aug 2007 No development reported - Preclinical for Severe acute respiratory syndrome (prevention) in France (unspecified route)
- 28 Apr 2004 Preclinical trials in Severe acute respiratory syndrome (prevention) in Belgium (unspecified route)